Brain Stimulation + Visual Training for Stroke-Related Vision Impairment
Trial Summary
What is the purpose of this trial?
This trial tests a new treatment for stroke patients who have lost part of their vision. The treatment combines visual exercises with gentle electrical brain stimulation to help improve vision. The goal is to see if this approach can help the brain recover and restore some lost vision.
Will I have to stop taking my current medications?
The trial protocol does not specify if you must stop taking your current medications. However, your medications will be reviewed by a doctor, and a decision will be made based on your medical history and current treatment.
What data supports the effectiveness of the treatment Brain Stimulation + Visual Training for Stroke-Related Vision Impairment?
Research shows that transcranial random noise stimulation (tRNS) can improve visual functions like contrast sensitivity and visual acuity in conditions like amblyopia, and virtual reality visual training has shown potential in improving visual perception and quality of life in patients with visual field loss. These findings suggest that similar techniques might help with stroke-related vision impairment.12345
Is transcranial random noise stimulation (tRNS) safe for humans?
How does the treatment of Brain Stimulation + Visual Training for Stroke-Related Vision Impairment differ from other treatments?
This treatment is unique because it combines computer-based visual training with transcranial random noise stimulation (tRNS), which enhances learning and recovery of visual functions more quickly and effectively than visual training alone. Unlike traditional methods that may take months, this approach can lead to significant improvements in just 10 days, with effects lasting up to 6 months.59101112
Research Team
Lorella Battelli
Principal Investigator
Beth Israel Deaconess Medical Center
Eligibility Criteria
This trial is for adults over 18 who've had their first ischemic stroke causing partial blindness due to damage in the primary visual cortex. They must have some intact visual areas, show a deficit in visual perception, and be able to follow the study protocol. Exclusions include hemorrhagic stroke, multiple strokes, complete reading loss, severe psychiatric conditions, attentional neglect, contraindications for tRNS treatment or pregnancy.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 10 daily sessions of tRNS with or without visual training, depending on the group assignment
Follow-up
Participants are monitored for changes in visual field and quality of life after treatment
Treatment Details
Interventions
- Computer Based Visual Training (Behavioural Intervention)
- Sham stimulation (Procedure)
- tRNS (Noninvasive Brain Stimulation)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor
Dr. Kevin Tabb
Beth Israel Deaconess Medical Center
Chief Executive Officer since 2021
MD from Hebrew University Hadassah Medical School
Dr. Chi Chang Daniel Siao
Beth Israel Deaconess Medical Center
Chief Medical Officer since 2023
MD from King George’s Medical University